TY - JOUR
T1 - Research to knowledge
T2 - promoting the training of physician-scientists in the biology of pregnancy
AU - Society for Maternal-Fetal Medicine (SMFM)
AU - SMFM Research Committee
AU - Sadovsky, Yoel
AU - Caughey, Aaron B.
AU - DiVito, Michelle
AU - D'Alton, Mary E.
AU - Murtha, Amy P.
N1 - Funding Information:
In our attempt to assess programmatic success, we recently surveyed the 20 scholars who graduated from the Foundation for SMFM-AAOGF program from 1992 through 2015. The Table summarizes key information from 19 graduates who completed the survey. Recognizing that the number of trainees is small, reflecting the young age of the program, and that there is no single measure of success for such programs, we used several success metrics reported by others assessing NIH and other programs. As shown in the Table , most program graduates (68%) defined their professional position as academic. The majority (74%) indicated that they are still engaged in research. Although the level of engagement is difficult to define, more than one fourth of the graduates indicated that they are engaged in research >60% of their time. In all, 74% published ≥10 manuscripts (as authors or coauthors) since the initiation of their training. Among grant recipients, as principal investigator (PI) or co-PI (excluding coinvestigators), 53% have received any research project grant and 37% received an R01. The well-defined metric of funded R01 as PI/co-PI compares well with the numbers for former K trainees, reported by the Review of NICHD Training and Career Development Programs, 16 which indicated that 36.8% of K12 trainees and 29.8% of individual K trainees received an R01 grant at some point after their K-level training. Even lower success rates were recently reported by Okeigwe et al, 17 who found that among K-award recipients from 1988 through 2009, only 22% were successful at obtaining an R01. Interestingly, they also found that sex, subspecialty, and educational degree did not affect the likelihood of an obstetrics and gynecology K-grant recipient to obtain independent funding, with a slight, statistically significant advantage for BIRCWH scholars to receive independent funding of any type compared with RSDP and WRHR scholars, and an insignificant trend for K08 awardees to receive an R01 compared with K12 awardees. 17
Funding Information:
The Foundation for the Society for Maternal-Fetal Medicine (SMFM) has sponsored a scholarship award since 1992. Its main goals have been to identify and attract promising scholars among maternal-fetal medicine trainees and junior faculty, stimulate their research interest, ensure excellent mentorship, protect and foster their career development, and nurture their intention to become productive and funded physician-scientists in the biology of pregnancy. Scholars were initially supported for only 1 year of training but this period was later extended to 2 years. In 2003, the Foundation for SMFM (at that time known as the Pregnancy Foundation) and the American Association of Obstetricians and Gynecologists Foundation (AAOGF), with support from the American Board of Obstetrics and Gynecology (ABOG), partnered to support a 3-year program designed to support the training of MD physician-scientists. Using the individual K-grant model, a national committee of maternal-fetal medicine physician-scientists oversees the program and the training of individual scholars. Unlike the NIH individual K award, the oversight committee provides close supervision of each trainee’s progress, mentoring, and environmental support, which is more aligned with the supervision provided in institutional K12 programs or the RSDP.
Publisher Copyright:
© 2017 Elsevier Inc.
PY - 2018/1
Y1 - 2018/1
N2 - Common disorders of pregnancy, such as preeclampsia, preterm birth, and fetal growth abnormalities, continue to challenge perinatal biologists seeking insights into disease pathogenesis that will result in better diagnosis, therapy, and disease prevention. These challenges have recently been intensified with discoveries that associate gestational diseases with long-term maternal and neonatal outcomes. Whereas modern high-throughput investigative tools enable scientists and clinicians to noninvasively probe the maternal-fetal genome, epigenome, and other analytes, their implications for clinical medicine remain uncertain. Bridging these knowledge gaps depends on strengthening the existing pool of scientists with expertise in basic, translational, and clinical tools to address pertinent questions in the biology of pregnancy. Although PhD researchers are critical in this quest, physician-scientists would facilitate the inquiry by bringing together clinical challenges and investigative tools, promoting a culture of intellectual curiosity among clinical providers, and helping transform discoveries into relevant knowledge and clinical solutions. Uncertainties related to future administration of health care, federal support for research, attrition of physician-scientists, and an inadequate supply of new scholars may jeopardize our ability to address these challenges. New initiatives are necessary to attract current scholars and future generations of researchers seeking expertise in the scientific method and to support them, through mentorship and guidance, in pursuing a career that combines scientific investigation with clinical medicine. These efforts will promote breadth and depth of inquiry into the biology of pregnancy and enhance the pace of translation of scientific discoveries into better medicine and disease prevention.
AB - Common disorders of pregnancy, such as preeclampsia, preterm birth, and fetal growth abnormalities, continue to challenge perinatal biologists seeking insights into disease pathogenesis that will result in better diagnosis, therapy, and disease prevention. These challenges have recently been intensified with discoveries that associate gestational diseases with long-term maternal and neonatal outcomes. Whereas modern high-throughput investigative tools enable scientists and clinicians to noninvasively probe the maternal-fetal genome, epigenome, and other analytes, their implications for clinical medicine remain uncertain. Bridging these knowledge gaps depends on strengthening the existing pool of scientists with expertise in basic, translational, and clinical tools to address pertinent questions in the biology of pregnancy. Although PhD researchers are critical in this quest, physician-scientists would facilitate the inquiry by bringing together clinical challenges and investigative tools, promoting a culture of intellectual curiosity among clinical providers, and helping transform discoveries into relevant knowledge and clinical solutions. Uncertainties related to future administration of health care, federal support for research, attrition of physician-scientists, and an inadequate supply of new scholars may jeopardize our ability to address these challenges. New initiatives are necessary to attract current scholars and future generations of researchers seeking expertise in the scientific method and to support them, through mentorship and guidance, in pursuing a career that combines scientific investigation with clinical medicine. These efforts will promote breadth and depth of inquiry into the biology of pregnancy and enhance the pace of translation of scientific discoveries into better medicine and disease prevention.
UR - http://www.scopus.com/inward/record.url?scp=85034783491&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85034783491&partnerID=8YFLogxK
U2 - 10.1016/j.ajog.2017.09.024
DO - 10.1016/j.ajog.2017.09.024
M3 - Article
C2 - 28993175
AN - SCOPUS:85034783491
SN - 0002-9378
VL - 218
SP - B9-B13
JO - American Journal of Obstetrics and Gynecology
JF - American Journal of Obstetrics and Gynecology
IS - 1
ER -